Enhanced NO Signaling in Patients with Takotsubo Cardiomyopathy: Short-Term Pain, Long-Term Gain?
Thanh H Nguyen, Christopher J Neil, Aaron L Sverdlov, Doan T Ngo, Wai P Chan, Tamila Heresztyn, Yuliy Y Chirkov, Dimitrios Tsikas, Michael P Frenneaux, John D Horowitz
CARDIOVASCULAR DRUGS AND THERAPY | SPRINGER | Published : 2013
PURPOSE: Little information is available concerning the mechanism(s) underlying Takotsubo cardiomyopathy (TTC), other than evidence of associated catecholamine secretion. Given the known effects of catecholamines on endothelial function, we tested the hypothesis that TTC might also be associated with impairment of nitric oxide (NO) signaling. We now report an evaluation of NO signaling in TTC patients (vs. aged-matched controls) in relation to (a) severity of the acute attack and (b) rate of recovery. METHODS: In 56 patients with TTC, we utilized (1) platelet responsiveness to NO and (2) plasma levels of asymmetric dimethylarginine (ADMA) as indices of integrity of the cyclic guanosine monop..View full abstract